The medical industry has two major characteristics: first, high degree of control; second, wide field and large subdivision. These two characteristics require investors to have their own set of logical methods when making decisions in this industry.
Highly regulated, need to pay attention to policy changes
" Medical care is a highly regulated industry because it is related to people's life and health. It is related to the aging and death of everyone." Song Longtao mentioned that in a medical technology generation, experiment, approval, marketization and even a medical service. The regulation of all aspects of the process, practice and so on are very strict.
The most obvious manifestation of this high regulation is the change in policy regulation. In the first half of 2016, the “Eight Measures†and “Comprehensive Clearance Notice†issued by the Beijing Municipal Health Planning Commission directly led to the sudden transformation of some Internet medical projects or the suspension of some businesses. The recent "Wei Zexi" incident also led to a total stop of immunotherapy.
This change in policy means that from the perspective of investment, it is necessary to familiarize the policy with the policy, always pay attention to the direction of the policy, and adapt to this trend. Taking the development of medical technology as an example, "If a technology is not recognized and allowed by the government's policies, it must not be market-oriented. If it cannot be market-oriented, it must not be big, it cannot be listed, or even be merged." Song Longtao said However, China's medical policy is also changing, so if a technology is very advanced and hopefully widely used in the market, then this technology should be continuously concerned, and future policies may be released.
Wide field, many subdivisions, first select the track and then select the player
There are many subdivisions in the medical industry. "There are dozens of departments in a hospital. These departments have subdivided diseases. There are tens of thousands of diseases in the world, which correspond to tens of thousands of medicines, medical devices, and Treatment method." This requires investors to choose the track before they invest, and then select the good players. Song Longtao told the arterial network, "If the track is short, the players you pick are more powerful, and you may hit the wall as soon as you run."
In vitro diagnosis is a "good track" chosen by Song Longtao. The hot-spot creatures invested in it and the Cap-Bios invested before the morning are typical representatives in the fields of immunodiagnosis and molecular diagnosis. In terms of market size, the market size of diagnostic reagents in China was 16.5 billion yuan in 2012, of which the market size of immunodiagnostic reagents was 5 billion yuan. In the next decade, the market size of diagnostic reagents in China will maintain a growth rate of 15%-20%. The annual amount can reach more than 20 billion yuan. Since the first half of 2014, the company has officially invested in hot-view creatures. In two years, Hotview Bio has grown from a loss-making team to a company with a net profit of more than 30 million yuan this year. Song Longtao explained, "At the time, my judgment was to diagnose the industry very much, and the products of the hot scene were both qualitative and quantitative. Its products have good reaction specificity, good sensitivity and high accuracy. In the domestic market, its The product effect is the same as that of Roche. The founder Lin is very diligent and has a strong execution. "It is understood that Hotview Bio has applied for 10 patents and has authorized 4 exclusive patents for use. At the end of 2015, The “National Technology Progress Award†is the only company that has received this honor in the field of in vitro diagnostics.
Yellow Clingstone Peaches, peeled, pitted, Yellow Peahc Halves, slices and dices, In Heavy Syrup.
Fomdas control product quality and safety from raw material origins by planting fresh Ams Peaches. About 1/3 of fresh Yellow Cling Peach are picked from Fomdas own orchards, and the rest 2/3 are purchased qualified suppliers. We have strict and complete qualified supplier assessment system for new supplier assessment. Every piece of fresh raw material are pesticides and heavy metal residual tested before putting into production of Canned Peaches In Heavy Syrup. Moreover, all peaches are selected on appearance, color and maturity, they are processed at the peak of freshness.
Fomdas Peaches In Heavy Syrup is natural and healthy, they are gluten free and Non-GMO. It's a good source of Vitamin C, a perfect snack for both kids and adults.
Fomdas Sliced Peahces In Heavy Syrup is shelf-stable, with it, you can enjoy good taste of fresh peaches anywhere and anytime.
Peaches In Heavy Syrup, Yellow Peach Halves, Sliced Peaches In Heavy Syrup, Canned Peaches In Heavy Syrup, Yellow Clingstone Peaches
ZHEJIANG FOMDAS FOODS CO., LTD. , https://www.fomdasfoods.com